Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 052954/0490 | |
| Pages: | 9 |
| | Recorded: | 06/16/2020 | | |
| Attorney Dkt #: | TP1006.US1 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/15/2022
|
Application #:
|
16646853
|
Filing Dt:
|
03/12/2020
|
|
Publication #:
|
|
Pub Dt:
|
09/03/2020
| | | | |
|
Title:
|
TREATMENT REGIMEN FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBITORS USING THE MCL-1 INHIBITOR ALVOCIDIB
|
|
|
Assignee
|
|
|
|
|
| 3900 N. TRAVERSE MOUNTAIN BLVD. |
| LEHI, UTAH 84043 |
|
|
Correspondence name and address
|
| |
DEBORAH A. MILLER
|
| |
84 WATERFORD DRIVE
|
| |
SUNOVION PHARMACEUTICALS INC.
|
| |
MARLBOROUGH, MA 01752
|
Search Results as of:
04/24/2024 08:37 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
